Rahul G Sangani
Overview
Explore the profile of Rahul G Sangani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
79
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mohamed R, Sangani R, Kamal K, LeMaster T, Rudisill T, Scott V, et al.
Med Adv
. 2025 Feb;
2(4):336-348.
PMID: 39931115
Background: Accurate staging systems are essential for assessing the severity of idiopathic pulmonary fibrosis (IPF) and guiding clinical management. This study aimed to evaluate the prognostic value of pulmonary comorbidities...
2.
Sangani R, Deepak V, Ghio A, Patel Z, Alshaikhnassir E, Vos J
Clin Pathol
. 2023 Nov;
16:2632010X231209878.
PMID: 37954231
Background: Peribronchiolar metaplasia (PBM) is considered a reaction to injury characterized by the proliferation of bronchiolar epithelium into immediately adjacent alveolar walls. While an association of PBM with diffuse interstitial...
3.
Ghio A, Stewart M, Sangani R, Pavlisko E, Roggli V
Int J Mol Sci
. 2023 Aug;
24(15).
PMID: 37569765
Theories of disease pathogenesis following asbestos exposure have focused on the participation of iron. After exposure, an open network of negatively charged functional groups on the fiber surface complexes host...
4.
Sangani R, Deepak V, Anwar J, Patel Z, Ghio A
Int J Chron Obstruct Pulmon Dis
. 2023 Apr;
18:431-446.
PMID: 37034898
Background: Cigarette smoking (CS)-related monocytosis contributes to the development of chronic lung injuries via complex mechanisms. We aim to determine correlations between measures of CS and monocytes, their capacities to...
5.
Sangani R, Deepak V, Ghio A, Forte M, Zulfikar R, Patel Z, et al.
BMC Pulm Med
. 2022 Apr;
22(1):172.
PMID: 35488260
Background: Cigarette smoking is a risk factor for interstitial lung abnormalities (ILAs) and interstitial lung diseases (ILDs). Investigation defining the relationships between ILAs/ILDs and clinical, radiographic, and pathologic findings in...
6.
Sangani R, Ghio A, Parker J
Am J Ind Med
. 2022 Feb;
65(5):425-426.
PMID: 35220613
No abstract available.
7.
Ghio A, Pavlisko E, Roggli V, Todd N, Sangani R
Int J Chron Obstruct Pulmon Dis
. 2022 Jan;
17:117-140.
PMID: 35046648
It is proposed that the mechanistic basis for non-neoplastic lung injury with cigarette smoking is a disruption of iron homeostasis in cells after exposure to cigarette smoke particle (CSP). Following...
8.
Sangani R, Ghio A, Mujahid H, Patel Z, Catherman K, Wen S, et al.
South Med J
. 2021 Jul;
114(7):424-431.
PMID: 34215896
Objectives: Obesity can be an independent predictor of fibrosis in tissues, including the liver, heart, and skin. We evaluated a rural Appalachian cohort of idiopathic pulmonary fibrosis (IPF) for its...
9.
Howdershelt L, Forte M, Sangani R
Case Rep Crit Care
. 2020 Aug;
2020:8825845.
PMID: 32774933
Paraneoplastic diarrhea is a commonly described complication of gastrointestinal tract or endocrine malignancies. It is an extremely rare complication of lung adenocarcinoma, with only one previously reported case in the...
10.
Forte M, Sangani R
Case Rep Oncol Med
. 2019 Aug;
2019:6185943.
PMID: 31467750
Osimertinib is an oral epithelial growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) used primarily in the treatment of metastatic non-small cell lung cancer. It is usually well tolerated with less...